Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material Threat Medical Countermeasure priority review voucher by the FDA.
- PEPID Extends Long Time Partnership with Data Soft Logic
- Don’t Go Camping Without These T.I.P.S. for Summer Injuries
- FDA Approves New Treatment for HSDD in Premenopausal Women
- FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks
- New Indication for Zerbaxa (ceftolozan & tazobactam) Battles Antimicrobial-resistant Infections